Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients
The proposed study is in the field of thoracic radiation oncology where radiation therapy is used to treat lung cancer. The primary objective of the early phase clinical trial will be to evaluate the safety of performing functional avoidance radiation therapy for lung cancer patients using 4D computed tomography (4DCT) ventilation imaging.
Checked against the public recordLast updated Jul 22, 2021 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Colorado, Denver
- Interventions being studied
- Radiation: Radiation therapy
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. Diagnosis of pathologically confirmed lung cancer by tumor biopsy and/or fine-need aspiration 2. Lung Cancer patients that will undergo definitive radiation therapy defined as 45-75 Gy as part of standard of care for their disease 3. 18 years of age or older 4. Signed informed consent 5. Planned curative intent chemotherapy, delivered concurrently or sequentially in combination with radiotherapy 6. The patient's 4DCT-ventilation image meets image heterogeneity criteria Exclusion Criteria: 1. Patients receiving Stereotactic Body Radiation Therapy 2. Patient receiving palliative radiation therapy (defined as less than 45 Gy)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Colorado Cancer CenterAurora, Colorado
- Beaumont Health SystemRoyal Oak, Michigan
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 22, 2021. Always confirm current availability with the study team.